These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29134439)

  • 1. Treatment-related survival associations of claudin-2 expression in fibroblasts of colorectal cancer.
    Mezheyeuski A; Strell C; Hrynchyk I; Guren TK; Dragomir A; Doroshenko T; Pashkova O; Gorgun J; Ruksha K; Pfeiffer P; Kure EH; Sorbye H; Edler D; Martling A; Glimelius B; Östman A; Portyanko A
    Virchows Arch; 2018 Mar; 472(3):395-405. PubMed ID: 29134439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of genes encoding tight junction proteins in colorectal cancer: frequent dysregulation of claudin-1, -8 and -12.
    Gröne J; Weber B; Staub E; Heinze M; Klaman I; Pilarsky C; Hermann K; Castanos-Velez E; Röpcke S; Mann B; Rosenthal A; Buhr HJ
    Int J Colorectal Dis; 2007 Jun; 22(6):651-9. PubMed ID: 17047970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing time to disease progression of irinotecan and oxaliplatin-based chemotherapies in colorectal cancer patients with liver only metastasis.
    Varol U; Karaca B; Cakar B; Sezgin C; Karabulut B; Uslu R
    Am J Clin Oncol; 2013 Aug; 36(4):388-91. PubMed ID: 22643568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Еxpression of claudin-1, 3, and 4 in colorectal cancer and polyps].
    Nefedova NА; Kharlova ОА; Malkov PG
    Arkh Patol; 2016; 78(3):11-19. PubMed ID: 27296001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
    Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
    Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
    Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
    Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low expression of claudin-1 and presence of poorly-differentiated tumor clusters correlate with poor prognosis in colorectal cancer.
    Shibutani M; Noda E; Maeda K; Nagahara H; Ohtani H; Hirakawa K
    Anticancer Res; 2013 Aug; 33(8):3301-6. PubMed ID: 23898096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen.
    Van Cutsem E; Tabernero J; Lakomy R; Prenen H; Prausová J; Macarulla T; Ruff P; van Hazel GA; Moiseyenko V; Ferry D; McKendrick J; Polikoff J; Tellier A; Castan R; Allegra C
    J Clin Oncol; 2012 Oct; 30(28):3499-506. PubMed ID: 22949147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer.
    Kinugasa T; Huo Q; Higashi D; Shibaguchi H; Kuroki M; Tanaka T; Futami K; Yamashita Y; Hachimine K; Maekawa S; Nabeshima K; Iwasaki H; Kuroki M
    Anticancer Res; 2007; 27(6A):3729-34. PubMed ID: 17970035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled phase ii study evaluating the reduction of neutropenia and febrile neutropenia in patients with colorectal cancer receiving pegfilgrastim with every-2-week chemotherapy.
    Hecht JR; Pillai M; Gollard R; Heim W; Swan F; Patel R; Dreiling L; Mo M; Malik I
    Clin Colorectal Cancer; 2010 Apr; 9(2):95-101. PubMed ID: 20378503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Claudin-Based Molecular Signature Identifies High-Risk, Chemoresistant Colorectal Cancer Patients.
    Gowrikumar S; Primeaux M; Pravoverov K; Wu C; Szeglin BC; Sauvé CG; Thapa I; Bastola D; Chen XS; Smith JJ; Singh AB; Dhawan P
    Cells; 2021 Aug; 10(9):. PubMed ID: 34571860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of olfactomedin 4 and claudin-18 in serrated neoplasia of the colorectum: a characteristic pattern is associated with sessile serrated lesion.
    Sentani K; Sakamoto N; Shimamoto F; Anami K; Oue N; Yasui W
    Histopathology; 2013 Jun; 62(7):1018-27. PubMed ID: 23570326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stromal expression of heat-shock protein 27 is associated with worse clinical outcome in patients with colorectal cancer lung metastases.
    Schweiger T; Nikolowsky C; Starlinger P; Traxler D; Zimmermann M; Birner P; Hegedüs B; Dome B; Bergmann M; Mildner M; Klepetko W; Hoetzenecker K; Ankersmit HJ
    PLoS One; 2015; 10(3):e0120724. PubMed ID: 25793600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collective migration of cancer-associated fibroblasts is enhanced by overexpression of tight junction-associated proteins claudin-11 and occludin.
    Karagiannis GS; Schaeffer DF; Cho CK; Musrap N; Saraon P; Batruch I; Grin A; Mitrovic B; Kirsch R; Riddell RH; Diamandis EP
    Mol Oncol; 2014 Mar; 8(2):178-95. PubMed ID: 24268521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of claudin-1, -3, -4, -5 and -7 proteins in low grade colorectal carcinoma of canines.
    Jakab C; Rusvai M; Gálfi P; Szabó Z; Szabára A; Kulka J
    Histol Histopathol; 2010 Jan; 25(1):55-62. PubMed ID: 19924641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive significance of long interspersed nucleotide element-1 methylation in advanced-stage colorectal cancer.
    Kaneko M; Kotake M; Bando H; Yamada T; Takemura H; Minamoto T
    BMC Cancer; 2016 Dec; 16(1):945. PubMed ID: 27955637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5-FU/LV plus irinotecan or irinotecan plus oxaliplatin as first-line treatment (FIRE 1-trial).
    Stahler A; Heinemann V; Giessen-Jung C; Crispin A; Schalhorn A; Stintzing S; Fischer von Weikersthal L; Vehling-Kaiser U; Stauch M; Quietzsch D; Held S; von Einem JC; Holch J; Neumann J; Kirchner T; Jung A; Modest DP
    Int J Cancer; 2016 Feb; 138(3):739-46. PubMed ID: 26284333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERCC1 and thymidylate synthase mRNA levels predict survival for colorectal cancer patients receiving combination oxaliplatin and fluorouracil chemotherapy.
    Shirota Y; Stoehlmacher J; Brabender J; Xiong YP; Uetake H; Danenberg KD; Groshen S; Tsao-Wei DD; Danenberg PV; Lenz HJ
    J Clin Oncol; 2001 Dec; 19(23):4298-304. PubMed ID: 11731512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. WNT5A Promoter Methylation Is Associated with Better Responses and Longer Progression-Free Survival in Colorectal Cancer Patients Treated with 5-Fluorouracil-Based Chemotherapy.
    Jiang G; Lin J; Wang W; Sun M; Chen K; Wang F
    Genet Test Mol Biomarkers; 2017 Feb; 21(2):74-79. PubMed ID: 28051879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.